The weight loss medications we provide at the Institute for Hormonal Balancesemaglutide and tirzepatideare both glucagon-like peptide-1 (GLP-1) receptor agonists, with tirzepatide also being a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
The national initiative is designed to give low-income Americans access to weight loss program treatments, which may include a GLP-1 prescription if eligible, at up to 50% lower cost, bringing life-changing care within reach of the populations historically priced out of it
Avoid freeze-thaw cycles for reconstituted peptide solutions, as each cycle degrades peptide integrity
Adults seeking metabolic support during weight loss may benefit after provider review
Together, these mechanisms create comprehensive research tools for investigating fundamental questions about musculoskeletal tissue engineering, biomechanical property optimization, and regenerative capacity in laboratory models of tendon, ligament, muscle, and bone repair
With medical guidance, semaglutide can be a powerful tool in a weight loss plan